Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.63 - $1.1 $13,356 - $23,320
-21,200 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$0.72 - $1.2 $5,040 - $8,400
7,000 Added 49.3%
21,200 $17,000
Q4 2021

Feb 14, 2022

SELL
$1.0 - $1.82 $600 - $1,092
-600 Reduced 4.05%
14,200 $15,000
Q3 2021

Nov 12, 2021

SELL
$1.53 - $1.85 $3,825 - $4,625
-2,500 Reduced 14.45%
14,800 $25,000
Q4 2020

Feb 12, 2021

BUY
$1.88 - $2.84 $9,400 - $14,200
5,000 Added 40.65%
17,300 $35,000
Q4 2019

Feb 12, 2020

BUY
$0.65 - $1.26 $7,995 - $15,498
12,300 New
12,300 $15,000

Others Institutions Holding NAVB

About NAVIDEA BIOPHARMACEUTICALS, INC.


  • Ticker NAVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,150,900
  • Description
  • Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...
More about NAVB
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.